Abstract
Fibromyalgia (FM) is a disease entity consisting of a heterogeneous cluster of symptoms that has thus far eluded identification of a causative etiology. The disease onset appears to follow physiological and/or psychological stressors and involves a subset of symptoms that are consistent with varied disorders found in multiple medical specialties to include rheumatology, immunology, endocrinology, neurology, and psychiatry. Owing to the heterogeneity of the symptom complex and the heretofore absence of serum markers that might serve as concrete diagnostic criteria, this disease has baffled clinicians and basic scientists alike. Recent findings regarding sleep architecture, immunology, and endocrinology have provided clues that may help in the understanding and resultant treatment of this entity. Women with fibromyalgia tend to present with an alpha-delta sleep anomaly, which when treated with a growth hormone secretagogue (GHS), reduces the rheumatological pain and restores slow-wave sleep architecture. These findings suggest the somatotrophic axis may be involved in the etiology and the treatment of this disorder. Those diagnosed with FM respond to various stressors with increased disruption of their physiological homeostasis. When compared to healthy agematched cohorts, there are quantitative differences in various neuroactive steroid levels, immunological markers, and feedback mechanisms. The varied physiological alterations in patients diagnosed with fibromyalgia when compared to controls will be discussed along with the potential treatment options for this population.
Similar content being viewed by others
References
Yunus, M. B., Arslan, S., and Aldag, J. C. (2002). Scand. J. Rheumatol. 31, 27–31.
Crofford, L. J. and Demitrack, M. A. (1996). Rheum. Dis. Clin. North Am. 22(2), 267–284.
Wolfe, F., Smyth, H. A., Yunus, M. B., et al. (1990). Arthritis Rheum. 33(2), 160–172.
Wallace, D. J., Linker-Israeli, M., Hallegua, D., Silverman, S., Silver, D., and Weisman, M. H. (2001). Rheumatology 40, 743–749.
Torphy, D. J., Papanicolaou, D. A., Lotsikas, A., Wilder, R. L., Chrousos, G. P., and Pillemer, S. R. (2000). Arthritis Rheum. 43, 472–880.
Toogood, A. A., O’Neill, P. A., and Shalet, S. M. (1996). J. Clin. Endocrinol. Metab. 81, 460–465.
Van Cauter, E., Leproult, R., and Plat, L. (2002). JAMA 284, 861–868.
Van Cauter, E., Plat, L., and Copinschi, G. (1998). Sleep 21(6), 553–566.
Dinser, R., Halama, T., and Hoffmann, A. (2000). J. Rheumatol. 27, 2482–2488.
Leal-Cerro, A., Povedano, J., Astorga, R., et al. (1999). J. Clin. Endocrinol. Metab. 84, 3378–3381.
Bennet, R. M., Clark, S. C., and Walczyk, J. (1998). Am. J. Med. 104, 227–231.
Leal-Cerro, A., Povedano, J., Ulied, A., et al. (2002). Presented at the Annual Scientific Proceedings of the Endocrine Society, San Francisco, CA (P1-238).
Lentz, M. J., Landis, C. A., Rothermel, J., and Shaver, J. L. F. (1999). J. Rheumatol. 26, 1586–1592.
Drewes, A. M. (1999). Rheumatology 38, 1035–1038.
Roizenblatt, S., Moldofsky, H., Benedito-Silva, A. A., and Tufik, S. (2001). Arthritis Rheum. 44, 222–230.
Moldofsky, H. (2001). Sleep Med. Rev. 5, 387–398.
Scharf, M. B., Hauck, M., Stover, R., McDannold, M., and Berkowitz, D. (1998). J. Rheumatol. 25, 1896–1990.
Chapman, I. M., Bach, M. A., Van Cauter, E., et al. (1996). J. Clin. Endocrinol. Metab. 81, 4249–4257.
Buijs, M. M., Burggraaf, J., Wijbrandts, C., et al. (2003). Am. J. Clin. Nutr. 77, 544–550.
Pijl, H., Langendonk, J. G., Burggraaf, J., et al. (2001). J. Clin. Endocrinol. Metab. 86, 5509–5515.
Paiva, E. S., Deodhar, A., Jones, K. D., and Bennett, R. (2002). Arthritis Rheum. 46, 1344–1350.
Rains, J. C. and Penzien, D. B. (2003). J. Psychosom. Res. 54, 77–83.
Shaver, J. L., Lentz, M., Landis, C. A., Heitkemper, M. M., Buchwald, D. S., and Woods, N. F. (1997). Res. Nurs. Health 20, 247–257.
Van Cauter, E., Plat, L., Scharf, M. B., et al. (1997). J. Clin. Invest. 100, 745–753.
Van Cauter, E., Plat, L., Scharf, M. B., et al. (1997). J. Pediatr. 128, S32-S37.
Smith, R. G., Feighner, S., Prendergast, K., Guan, X., and Howard, A. (1999). Trends Endocrinol. Metab. 10, 128–135.
Copinschi, G., Leproult, R., Van Onderbergen, A., et al. (1997). Neuroendocrinology 66, 278–286.
Dessein, P. H., Shipton, E. A., Joffe, B. I., Hadebe, D. P., Stanwix, A. E., and Van der Merwe, B. A. (1999). Pain 83, 313–319.
Landis, C. A., Lentz, M. J., Rothermel, J., et al. (2001). J. Clin. Endocrinol. Metab. 86, 1672–1678.
Zumoff, B., Strain, G. W., Miller, L. K., and Rosner, W. (1995). J. Clin. Endocrinol. Metab. 80, 1429–1430.
Orentreich, N., Brind, J. L., Rizer, R. L., and Vogelman, J. H. (1984). J. Clin. Endocrinol. Metab. 59, 551–555.
Rubino, S., Stomati, M., Bersi, C., et al. (1998). Maturitas 28, 251–257.
Parker, C. R., Mixon, R. L., Brissie, R. M., and Grizzle, W. E. (1997). J. Clin. Endocrinol. Metab. 82, 3898–3901.
Burger, H. G. (1996). Maturitas 23, 129–136.
Cioffi, M., Esposito, K., Vietri, M. T., et al. (2002). Maturitas 41, 187–192.
Bulow, B., Hagmar, L., Orbaek, P., Osterberg, K., and Erfurth, E. M. (2002). Clin. Endocrinol. (Oxf.) 56, 183–193.
Park, D. C., Glass, J. M., Minear, M., and Crofford, L. J. (2001). Arthritis Rheum. 44, 2125–2133.
Grace, G. M., Nielson, W. R., Hopkins, M., and Berg, M. (1999). J. Clin. Exp. Neuropsychol. 21, 477–487.
Aleman, A., Verhaar, H. J., and De Haan, E. H. (1999). J. Clin. Endocrinol. Metab. 84, 471–475.
Deijen, J. B., de Boer, H., and van der Veen, E. A. (1998). Psychoneuroendocrinology 23, 45–55.
Kessler, R. C. (2003). J. Affect Dis. 74, 5–13.
Faische, R., Fideleff, H. L., Moisezowicz, J., Frieder, P., Pagano, S. M., and Holland, M. (1995). Psychoneuroendocrinology 20, 727–733.
Schmidt, P. J., Murphy, J. H., Haq, H., Danaceau, M. A., and St. Clair, L. S. (2002). Psychoneuroendocrinology 27, 907–920.
Maes, M., Meltzer, H. Y., Bosmans, E., et al. (1995). J. Affect Dis. 34, 301–309.
Haden, S. T., Glowacki, J., Hurwitz, S., Rose, C., and LeBoff, M. S. (2000). Calcif. Tissues Int. 66, 414–418.
Parnet, P., Kelley, K. W., Bluthe, R. M., and Dantzer, R. (2002). J. Neuroimmunol. 125, 5–14.
Kelly, K. W., Hutchison, K., French, R., et al. (1997). Ann. NY Acad. Sci. 823, 234–246.
Russel, I. (2002). Rheum. Dis. Clin. North Am. 28, 329–342.
Russel, I. J., Orr, M. D., Littman, B., et al. (1994). Arthritis Rheum. 37, 1593–1601.
Casson, P. R., Elkind-Hirsch, K. E., Busterm, J. E., Hornsby, P. J., Carson, S. A., and Snabes, M. C. (1997). Obstet. Gynecol. 90, 995–998.
Helle, S. I., Omsjo I. H., Hughes S. C., et al. (1996). Clin. Endocrinol. 45, 727–732.
Lieman, H. J., Adel, T. E., Forest, C., Von Hagen, S., and Santoro, N. (2001). J. Clin. Endocrinol. Metab. 86, 3918–3923.
Hartmann, B. W., Kirchengast, S., Albrecht, A. E., Laml, T., Huber, J. C., and Soregi, G. (1997). Gynecol. Endocrinol. 11, 43–50.
Hassan, H. A., Enright, W. H., Tucker, H. A., and Merkel, R. A. (2001). Steroids 66, 71–80.
Singer, F. and Zumoff, B. (1992). Steroids 57, 86–89.
Bernton, E., Hoover, D., Galloway, R., and Popp, K. (1995). Ann. NY Acad. Sci. 772, 217–231.
Papadopoulos, A. D. and Wardlaw, S. L. (2000). Neuroimmunomodulation 8, 39–44.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shuer, M.L. Fibromyalgia. Endocr 22, 67–75 (2003). https://doi.org/10.1385/ENDO:22:1:67
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:22:1:67